Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
-
Shares outstanding
-
239,647,920
-
Total 13F shares
-
35,195,775
-
Share change
-
-1,650,572
-
Total reported value
-
$9,066,882,359
-
Put/Call ratio
-
133%
-
Price per share
-
$257.80
-
Number of holders
-
334
-
Value change
-
-$433,429,701
-
Number of buys
-
170
-
Number of sells
-
154
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q4 2021
As of 31 Dec 2021 BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) had 334 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 35,195,775 shares of stock of the company.
Largest 10 holders included BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, JENNISON ASSOCIATES LLC, Pendal Group Ltd, Capital World Investors, Fosun International Ltd, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., COATUE MANAGEMENT LLC, and DEUTSCHE BANK AG\.
This table shows 334 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.